Latest filing published 03 Jun 2025 for bluebird bio, Inc.. Read the official filing
No signal scores available.
This profile gathers the share dealings of O. James Sterling in bluebird bio, Inc. In total, 2 filings cover trades dated from 30 September 2024 to 2 June 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 3 June 2025 came the latest disclosure, a transaction in bluebird bio, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations